Mille viae in eukaryotic mRNA decapping

Valkov, Eugene; Jonas, Stefanie; Weichenrieder, Oliver

doi:10.1016/j.sbi.2017.05.009

Item

ITEM ACTIONSEXPORT

Add to Basket

Please note that a newer version of this item is available:
https://pure.mpg.de/pubman/item/item_2638071_6

DetailsSummary

Released

Journal Article

Mille viae in eukaryotic mRNA decapping

MPS-Authors

Valkov, Eugene
Max Planck Institute for Developmental Biology, Max Planck Society;

Weichenrieder, Oliver
Max Planck Institute for Developmental Biology, Max Planck Society;

External Resource

https://www.sciencedirect.com/science/article/pii/S0959440X17300210?via%3Dihub
(Publisher version)

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Valkov, E., Jonas, S., & Weichenrieder, O. (2017). Mille viae in eukaryotic mRNA decapping. Current Opinion in Structural Biology, 47, 40-51. doi:10.1016/j.sbi.2017.05.009.

Cite as: https://hdl.handle.net/21.11116/0000-0002-1370-A

Abstract

Cellular mRNA levels are regulated via rates of transcription and decay. Since the removal of the mRNA 5'-cap by the decapping enzyme DCP2 is generally an irreversible step towards decay, it requires regulation. Control of DCP2 activity is likely effected by two interdependent means: by conformational control of the DCP2-DCP1 complex, and by assembly control of the decapping network, an array of mutually interacting effector proteins. Here, we compare three recent and conformationally distinct crystal structures of the DCP2-DCP1 decapping complex in the presence of substrate analogs and decapping enhancers and we discuss alternative substrate recognition modes for the catalytic domain of DCP2. Together with structure-based insight into decapping network assembly, we propose that DCP2-mediated decapping follows more than one path.